Immuron Ltd. Registered Shares o.N.

Sector and Industry

Healthcare, Healthcare Services

Performance (1Y)

53.62%

Market Cap

-

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

-0.01 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
UnitedHealth Group Inc.254.66 Bil.396.73 Bil.24.94
-19.75 %
0.00
-
Thermo Fisher Scientific Inc.185.62 Bil.39.50 Bil.32.67
+1.45 %
0.00
-
Danaher Corp.137.79 Bil.21.78 Bil.45.36
-11.47 %
0.00
-
McKesson Corporation90.13 Bil.348.09 Bil.22.55
+33.83 %
0.00
-
HCA Healthcare Inc.89.28 Bil.67.01 Bil.16.48
+12.93 %
0.00
-
Elevance Health Inc.65.88 Bil.176.51 Bil.13.91
-9.22 %
0.00
-
The Cigna Group61.74 Bil.243.65 Bil.12.41
+66.33 %
0.00
-
Cencora Inc.51.58 Bil.291.15 Bil.39.26
+1.16 %
0.00
-
IDEXX Laboratories Inc.45.92 Bil.3.81 Bil.51.74
+14.41 %
0.00
-
Zoetis Inc.45.52 Bil.8.39 Bil.20.89
+3.10 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE0.013 G0 Units
PRICE DETERMINATION TIME07/22/2026 / 09:17:53 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW0.0130.013
PREV. DAY'S PRICE0.016 (07/21)
CHANGE DAY BEFORE
-0.00
-18.75 %
52 WEEK HIGH / LOW0.0565 (11/05)0.007 (03/23)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
-0.01-0.02-0.010.000.00
DIVIDENDS PER SHARE
0.000.000.00--
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
-----
PRICE - BOOK RATIO
0.871.581.77--
PRICE - SALES RATIO
9.474.091.93--
PRICE - CASH FLOW RATIO
-----
Further Key Figures

Master Data

WKN
A0RDPK
ISIN
AU000000IMC7
SYMBOL
ANW
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
IMMURON LTD
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Healthcare Services
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-11.11 %
60.00 %
6.67 %
14.29 %
-53.62 %
-61.45 %
-82.68 %
-11.11 %
HIGH0.020.030.030.030.060.090.090.03
LOW0.020.010.010.010.010.010.010.01

Dividende

pro Aktie
IMMURON LTD does not deliver dividend information

Company profile

Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. It operates through the Hyper-immune Products and Research and Development (R&D) segments. The Hyper-immune Products segment includes income and expenses directly attributable to Travelan and Protectyn activities. The Research and Development segment refers to the group’s R&D projects performed in Australia and United States. The company was founded on January 13, 1994, and is headquartered in Blackburn, Australia.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.